CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,166,272 | -35.4% | 573,600 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $4,898,544 | -7.4% | 573,600 | -0.3% | 0.01% | 0.0% |
| Q1 2023 | $5,289,332 | -11.2% | 575,553 | -1.3% | 0.01% | -14.3% |
| Q4 2022 | $5,956,126 | -30.6% | 583,362 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $8,587,000 | +37.2% | 583,362 | 0.0% | 0.01% | +57.1% |
| Q2 2022 | $6,259,000 | -0.5% | 583,362 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $6,289,000 | -85.5% | 583,362 | -78.1% | 0.01% | -86.7% |
| Q4 2021 | $43,519,000 | -23.8% | 2,666,600 | 0.0% | 0.04% | -28.6% |
| Q3 2021 | $57,092,000 | – | 2,666,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |